Cancellations and suspensions
This database records details of medicines and medical devices that have been cancelled or suspended, and no longer appear in the ARTG.
Following a review by the TGA, complementary medicines can be cancelled from the Australian Register of Therapeutic Goods. These cancellations are made by the Secretary under section 30 of the Therapeutic Goods Act 1989.
Where other actions are taken in relation to safety, a link to the TGA's safety alert will be included in the database under 'Further information'.
The reasons for a cancellation are stated in the database below under 'Grounds for cancellation'.
The heading 'Decision status' provides updated information about cancellation decisions, for example information about any decision to revoke a cancellation decision. It will not appear in every entry.
To find out whether a product is currently authorised for supply in Australia, check the ARTG.
Last updated
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Action
- Medical device cancellation (851)
- Medicine suspension (506)
- Complementary medicine cancellation (205)
- Medical device suspension (87)
- Medicine cancellation (59)
- Revocation of a TGA issued Conformity Assessment Certificate (55)
- Voluntary revocation at the request of the manufacturer (39)
- Medical device cancellation - certain devices within an entry (23)
- Registered medicine cancellation (14)
- Medical device cancellation - requested by the sponsor - certain devices within an entry (8)
- Medical device cancellation (7)
- Listed medicine cancellation (4)
- Listed medicine cancellation (4)
- Revocation of a TGA issued Conformity Assessment Certificate. (3)
- Revocation of medical device suspension (3)
- Revoked medicine suspension (2)
- AFT Pharmaceuticals Pty Ltd (1)
- Alphapharm Pty Ltd (1)
- Complementary Medicine Cancellation (1)
- Complementary medicine cancellation (1)
- Medical device cancellation (1)
- Suspension from the ARTG under subsection s41GA(1)(b) (1)
- Voluntary revocation at the request of the manufacturer. (1)
Find out more about Cancellations and Suspensions.
Search
1910 result(s) found, displaying 1076 to 1100
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 21/01/2021
-
Cancellation or suspensionRegulatory action due to The certification under paragraphs 26A(2)(j) and 26A(2)(ja) of the Act is incorrect (paragraph 30(2)(ba) of the Act).The presentation of the listed goods is unacceptable (paragraph 30(2)(aa) of the Act)., effective 15/01/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 14/01/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 14/01/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 14/01/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 12/01/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 12/01/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 12/01/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 12/01/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 11/01/2021
-
Cancellation or suspensionRegulatory action due to Non response following a s41JA, effective 07/01/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 06/01/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 24/12/2020
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 24/12/2020
-
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that a statement made in, or in connection with, the application for listing of the goods was false or misleading in a material particular. As there was insufficient evidence to support the indications for the product, the certification made under s.26A(2)(ja) of the Act was incorrect. It appeared to the Secretary that the presentation of the goods was unacceptable., effective 23/12/2020
-
Cancellation or suspensionRegulatory action due to The product is an excluded good for the purposes of the Act, that is, the product is determined not to be a therapeutic good. Therefore the certification made by the sponsor under paragraph 41FD(a) of the Act in the application for inclusion, that the product is a medical device, is incorrect., effective 18/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Non response following s41JA, effective 17/12/2020
Last updated